IP30-12: Evaluating deep early tumor shrinkage in metastatic upper tract urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab
Saturday, May 16, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!